Novartis AG is 127.3x more valuable than Day One Biopharmaceuticals, Inc. by market capitalization ($283.13 B vs $2.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DAWN | NVS |
|---|---|---|
| Market cap | $2.22 B | $283.13 B |
| US-listed rank | #2027 | #47 |
| Revenue (latest FY) | $158.18M | - |
| Net income (latest FY) | -$107.32B | - |
| Net margin | -67847.2% | - |
| SEC filings | 493 | 947 |
Novartis AG is 127.3x more valuable than Day One Biopharmaceuticals, Inc. by market capitalization ($283.13 B vs $2.22 B).
Full pages: Day One Biopharmaceuticals, Inc. and Novartis AG, or browse the full rankings.